Histology
Carcinoma of Unknown Primary
CI-CAN-00002109Explore in graph →
4,156 active trials54 approved drugs532 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00002109Explore in graph →
Clinical trials
14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,893)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01214343 | Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC | unknown | Phase 3 | 190 | Ministry of Health, Labour and Welfare, JapanOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01298284 | A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol | unknown | Phase 4 | 60 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01373736 | 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | unknown | Phase 3 | — | Vancouver Coastal HealthOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
| NCT01308645 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT01363466 | Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer | terminated | Phase 3 | 61 | UNICANCEROTHER | 1 | Jun 1, 2011 | clinicaltrials |
| NCT00140075 | Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer | completed | Phase 3 | 606 | PfizerINDUSTRY | 1 | May 26, 2011 | clinicaltrials |
| NCT01077869 | A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis | terminated | — | 10 | University Hospital, GhentOTHER | 1 | May 26, 2011 | clinicaltrials |
| NCT01351194 | Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | May 26, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT01343212 | Stiffness Measurement of Liver Tumors and Visceral Parenchyma | unknown | — | 50 | China Medical University HospitalOTHER | 1 | May 18, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT01328691 | Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus | completed | — | 118 | Seoul National University HospitalOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00470340 | Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients(GEMOXIAL) | terminated | Phase 3 | 263 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 5, 2011 | clinicaltrials |
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | completed | Phase 1 | 24 | Bristol-Myers SquibbINDUSTRY | 2 | May 4, 2011 | clinicaltrials |
| NCT01126138 | Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC) | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00216216 | Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer | terminated | Phase 2 | 43 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT01341132 | Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents | unknown | — | 75 | San Francisco Veterans Affairs Medical CenterFED | 1 | Apr 25, 2011 | clinicaltrials |
| NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Apr 19, 2011 | clinicaltrials |
| NCT01336049 | Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Peking UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT01259193 | Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT01328223 | Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma | unknown | — | 45 | China Medical University HospitalOTHER | 1 | Apr 4, 2011 | clinicaltrials |
| NCT01322477 | Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency(HCC) | unknown | — | 25 | Hadassah Medical OrganizationOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01319942 | Combined Radiotherapy and Sorafenib in Patients With Hepatoma | unknown | — | 45 | China Medical University HospitalOTHER | 1 | Mar 22, 2011 | clinicaltrials |
| NCT00875381 | Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin | completed | — | 100 | Mayo ClinicOTHER | 0 | Mar 15, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01310062 | The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer | unknown | — | 1,600 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00178698 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors(FR-WB-TT/che) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00225927 | Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers | completed | N/A | 333 | McMaster UniversityOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00117351 | VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features | terminated | Phase 2 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 17, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00233636 | Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck | withdrawn | Phase 2 | 28 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00065572 | Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) | suspended | Phase 2 | — | AstraZenecaINDUSTRY | 1 | Jan 26, 2011 | clinicaltrials |
| NCT01281683 | Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00411151 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | completed | Phase 2 | 52 | Johannes Gutenberg University MainzOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01277653 | Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma | unknown | — | 1,000 | Yonsei UniversityOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00990860 | Study in Asia of the Combination of TACE With Sorafenib in HCC Patients(START) | unknown | Phase 2 | 36 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 5, 2011 | clinicaltrials |
| NCT01270178 | Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy | unknown | — | 420 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00822991 | Sonazoid Enhanced Liver Cancer Trial for Early Detection | unknown | N/A | 760 | Kindai UniversityOTHER | 1 | Dec 30, 2010 | clinicaltrials |
| NCT01266707 | Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma | unknown | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01265472 | Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy | unknown | — | 100 | Rambam Health Care CampusOTHER | 0 | Dec 23, 2010 | clinicaltrials |
| NCT01254838 | Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 | — | Iwate Medical UniversityOTHER | 0 | Dec 7, 2010 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
| NCT01249053 | Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT01249066 | Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01247506 | Different Genetic Features Associated With Hepatic Carcinogenesis | unknown | — | 160 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Jun 15, 2011source: clinicaltrials